The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Insulin delivery methods: Past, present and future
Open accessAbstract
Many patients with advanced type 2 diabetes mellitus (T2DM) and all patients with T1DM require insulin to keep blood glucose levels in the target range. The most common route of insulin administration is subcutaneous insulin injections. There are many ways to deliver insulin subcutaneously such as vials and syringes, insulin pens, and insulin pumps. Though subcutaneous insulin delivery is the standard route of insulin administration, it is associated with injection pain, needle phobia, lipodystrophy, noncompliance and peripheral hyperinsulinemia. Therefore, the need exists for delivering insulin in a minimally invasive or noninvasive and in most physiological way. Inhaled insulin was the first approved noninvasive and alternative way to deliver insulin, but it has been withdrawn from the market. Technologies are being explored to make the noninvasive delivery of insulin possible. Some of the routes of insulin administration that are under investigation are oral, buccal, nasal, peritoneal and transdermal. This review article focuses on the past, present and future of various insulin delivery techniques. This article has focused on different possible routes of insulin administration with its advantages and limitation and possible scope for the new drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 1×
“[5] However, IIT results in increased risk for hypoglycemia, which is a major obstacle in achieving glycemic targets.[6,7] Therefore, emphasis has evolved to achieving tight glycemic control with minimal hypoglycemia by focusing on delivering insulin that mimics endogenous insulin secretion by the pancreas.”
BackgroundCraft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652 · cited 1×
“[43] In clinical trials, TS reduced the severity of nocturnal hypoglycemia by 30-40% and reduced the duration of severe hypoglycemia without altering A1c values.[44,45] Recently, the TS system has been approved by US Food and Drug Administration (FDA) after having been approved in 2009 in other countries.”
Weissberg-Benchell, J., Antisdel-Lomaglio, J., & Seshadri, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1079 · Cited by 551
Pickup, J., Mattock, M., & Kerry, S. (2002) · BMJ · doi:10.1136/bmj.324.7339.705 · Cited by 483
Microneedles: an emerging transdermal drug delivery system
Bariya, S. H., Gohel, M. C., Mehta, T. A., & Sharma, O. P. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01369.x · Cited by 455
Quantitative study of insulin secretion and clearance in normal and obese subjects
Polonsky, K. S., Given, B. D., Hirsch, L., Shapiro, E. T., Tillil, H., Beebe, C., Galloway, J. A., Frank, B. H., Karrison, T., & Van Cauter, E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113338 · Cited by 444
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4127 · Cited by 412
Nasal drug delivery — Recent developments and future prospects
Illum, L. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.024 · Cited by 287
Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery
Malakar, J., Sen, S. O., Nayak, A. K., & Sen, K. K. (2012) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.02.001 · Cited by 273
(1991) · PubMed · Cited by 245
Polymeric hydrogels for oral insulin delivery
Chaturvedi, K., Ganguly, K., Nadagouda, M. N., & Aminabhavi, T. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.005 · Cited by 244
Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections
Retnakaran, R., Hochman, J., DeVries, J. H., Hanaire-Broutin, H., Heine, R. J., Melki, V., & Zinman, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2590 · Cited by 215
Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin
Patton, J. S., Bukar, J. G., & Eldon, M. A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443120-00002 · Cited by 188
Intranasal Aerosolized Insulin: Mixed-Meal Studies and Long-Term Use in Type I Diabetes
Salzman, R., Manson, J. E., Griffing, G. T., Kimmerle, R., Ruderman, N., McCall, A., Stoltz, E. I., Mullin, C., Small, D., Armstrong, J., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121702 · Cited by 187
Maniatis, A. K., Klingensmith, G. J., Slover, R. H., Mowry, C. J., & Chase, H. P. (2001) · Pediatrics · doi:10.1542/peds.107.2.351 · Cited by 176
An overview of natural polymers for oral insulin delivery
Sonia, T. A., & Sharma, C. P. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.019 · Cited by 170
Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy
Danne, T., Kordonouri, O., Holder, M., Haberland, H., Golembowski, S., Remus, K., Bläsig, S., Wadien, T., Zierow, S., Hartmann, R., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0084 · Cited by 161
Intranasal insulin as a therapeutic option in the treatment of cognitive impairments
Benedict, C., Frey, W. H., Schiöth, H. B., Schultes, B., Born, J., & Hallschmid, M. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.026 · Cited by 159
Severe Hypoglycemia Predicts Mortality in Diabetes
Cryer, P. E. (2012) · Diabetes Care · doi:10.2337/dc12-0749 · Cited by 158
Nanoparticle strategies for the oral delivery of insulin
Damgé, C., Reis, C. P., & Maincent, P. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.45 · Cited by 154
Oral Insulin and Buccal Insulin: A Critical Reappraisal
Heinemann, L., & Jacques, Y. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300323 · Cited by 154
Garg, S., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Shin, J., Welsh, J. B., & Kaufman, F. R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0292 · Cited by 138 · cited 1×
“[41] 2 h of insulin suspension is not associated with severe hyperglycemia and/ or diabetic ketoacidosis[42] or more likelihood of ketone.”
BackgroundMüller–Godeffroy, E., Treichel, S., Wagner, V. M., & on behalf of the German Working Group for Paediatric Pump Therapy (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02707.x · Cited by 128
Oral Insulin: The Rationale for This Approach and Current Developments
Arbit, E., & Kidron, M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300322 · Cited by 128
Oral colon delivery of insulin with the aid of functional adjuvants
Maroni, A., Zema, L., Curto, M. D. D., Foppoli, A., & Gazzaniga, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.006 · Cited by 127
Evolution of Diabetes Insulin Delivery Devices
Sélam, J.-L. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400302 · Cited by 118
Iontophoresis-Based Transdermal Delivery Systems
Kanikkannan, N. (2002) · BioDrugs · doi:10.2165/00063030-200216050-00003 · Cited by 111
Dead-in-bed syndrome in young diabetic patients.
Søvik, O., & Thordarson, H. B. (1999) · PubMed · Cited by 97
Hepatic-Directed Vesicle Insulin: A Review of Formulation Development and Preclinical Evaluation
Geho, W. B., Geho, H. C., Lau, J. R., & Gana, T. J. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300627 · Cited by 96
Garg, S. K., Voelmle, M. K., Beatson, C. R., Miller, H. A., Crew, L. B., Freson, B. J., & Hazenfield, R. M. (2011) · Diabetes Care · doi:10.2337/dc10-1852 · Cited by 85
Closed-Loop System in the Management of Diabetes: Past, Present, and Future
Shah, V. N., Shoskes, A., Tawfik, B., & Garg, S. K. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0193 · Cited by 84
Self-citationInsulin therapies: Current and future trends at dawn
Yaturu, S. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i1.1 · Cited by 74
Challenges and advances in nanoparticle-based oral insulin delivery
Rekha, M. R., & Sharma, C. P. (2009) · Expert Review of Medical Devices · doi:10.1586/erd.09.43 · Cited by 74
Parenteral absorption of insulin from the lung in diabetic children
Elliott, R. B., EDGAR, B. W., Pilcher, C. C., et al. (1987) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1987.tb00275.x · Cited by 73
Factors Affecting Use of Insulin Pens by Patients With Type 2 Diabetes
Rubin, R. R., & Peyrot, M. F. (2008) · Diabetes Care · doi:10.2337/dc07-1899 · Cited by 72
Technosphere ® Insulin Technology
Richardson, P. C., & Boss, A. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0212 · Cited by 70
Gin, H., Renard, É., Melki, V., et al. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70075-7 · Cited by 66
Kreugel, G., Keers, J. C., Kerstens, M. N., & Wolffenbuttel, B. H. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0010 · Cited by 66
Renard, É. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200429 · Cited by 66
Heinemann, L. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02276.x · Cited by 64
Transdermal Insulin Delivery Using Microdermabrasion
Andrews, S., Lee, J. W., Choi, S., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0435-4 · Cited by 63
Emerging diabetes therapies and technologies
Moser, E. G., Morris, A. A., & Garg, S. K. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.01.027 · Cited by 63
Botz, C. K., LEIBEL, B. S., Zingg, W., et al. (1976) · Diabetes · doi:10.2337/diab.25.8.691 · Cited by 63
Heinemann, L. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02577.x · Cited by 63
A Review of Inhaled Technosphere Insulin
Neumiller, J. J., Campbell, R. K., & Wood, L. D. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p055 · Cited by 60
Is There a Place for Insulin Pump Therapy in Your Practice?
Skyler, J. S., Ponder, S., Kruger, D. F., Matheson, D., & Parkin, C. G. (2007) · Clinical Diabetes · doi:10.2337/diaclin.25.2.50 · Cited by 59
Long-Term Use of Intranasal Insulin in Insulin-Dependent Diabetic Patients
Frauman, A. G., Cooper, M. E., Parsons, B. J., Jerums, G., & Louis, W. J. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.573 · Cited by 55
Vaughn, D. E., & Muchmore, D. B. (2011) · Endocrine Practice · doi:10.4158/ep11297.ra · Cited by 54
Insulin Delivery Device Technology 2012: Where are We after 90 Years?
Fry, A. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600428 · Cited by 53
Evolution of Devices in Diabetes Management
Penfornis, A., Personeni, E., & Borot, S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0058 · Cited by 49 · cited 6×
“Viral Shah, MD, Barbara Davis Center for Diabetes, 1775 Aurora Ct, MS A140, Colorado, USA.”
BackgroundMethodInfluentialAronson, R., Gibney, M. A., Oza, K., Bérubé, J., Kassler-Taub, K., & Hirsch, L. J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.05.020 · Cited by 48
Beck, R. W., Raghinaru, D., Wadwa, R. P., Chase, H. P., Maahs, D. M., Buckingham, B. A., & for the In Home Closed Loop Study Group (2014) · Diabetes Care · doi:10.2337/dc13-2775 · Cited by 44
Self-citationClosed-loop insulin delivery: towards improved diabetes care.
Kumareswaran, K., Evans, M. L., & Hovorka, R. (2012) · PubMed · Cited by 43
Diabetes care - insulin delivery in a changing world.
Marcus, A. O. (2008) · PubMed · Cited by 39
Olsen, B. S., Lilleøre, S. K., Korsholm, C. N., & Kracht, T. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400622 · Cited by 38
Pfützner, A., Bailey, T. S., Campos, C., Kahn, D. M., Ambers, E., Niemeyer, M., Guerrero, G., Klonoff, D. C., & Nayberg, I. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.775112 · Cited by 37
HumaPen®Memoir™: a novel insulin-injecting pen with a dose-memory feature
Ignaut, D. A., & Venekamp, W. J. R. R. (2007) · Expert Review of Medical Devices · doi:10.1586/17434440.4.6.793 · Cited by 35
Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes
Burdick, P., Cooper, S., Horner, B., Cobry, E. C., McFann, K., & Chase, H. P. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00449.x · Cited by 29
Brazg, R., Bailey, T. S., Garg, S. K., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Nguyen, X., Shin, J., Welsh, J. B., & Lee, S. W. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500621 · Cited by 28
Shah, V. N., Moser, E. G., Blau, A., Dhingra, M., & Garg, S. K. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0228 · Cited by 27
Self-citationAdvances in insulin delivery systems and devices: Beyond the vial and syringe
Flood, T. M. (2006) · Insulin · doi:10.1016/s1557-0843(06)80019-9 · Cited by 26
Cohen, O., Körner, A., Chlup, R., Zoupas, C., Константинович, Р. А., Wudi, K., Bartášková, D., Pappas, A., Niederland, T., Taybani, Z. J., et al. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300429 · Cited by 26
Freckmann, G., Pleus, S., Haug, C., Bitton, G., & Nagar, R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600407 · Cited by 24
Exubera Inhaled Insulin in Patients with Type 1 and Type 2 Diabetes: The First 12 Months
Alabraba, V., Farnsworth, A., Leigh, R., Dodson, P. M., Gough, S. C. L., & Smyth, T. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0131 · Cited by 24
Oral Delivery of Insulin: Novel Approaches
Amani, M. (2012) · InTech eBooks · doi:10.5772/52265 · Cited by 23
Preference for a new prefilled insulin pen compared with the original pen
Garg, S. K., Bailey, T. S., DeLuzio, T., & Pollom, D. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.630721 · Cited by 19
Freckmann, G., Pleus, S., Westhoff, A., Krinelke, L., Buhr, A., Jendrike, N. R. M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600215 · Cited by 18
Use of Non-Insulin Therapies for Type 1 Diabetes
Garg, S. K., Michels, A. W., & Shah, V. N. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0281 · Cited by 15
Self-citationXue, L., & Mikkelsen, K. H. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.761970 · Cited by 7
Cited by
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Insulin delivery systems combined with microneedle technology
Jin, X., Zhu, D. D., Chen, B. Z., Ashfaq, M., & Guo, X. D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.011 · Cited by 275
Identification of barriers to insulin therapy and approaches to overcoming them
Russell‐Jones, D., Pouwer, F., & Khunti, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13132 · Cited by 238
Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
Kesavadev, J., Saboo, B., Krishna, M. B., & Krishnan, G. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00831-z · Cited by 221
Safety of intranasal human insulin: A review
Schmid, V., Kullmann, S., Gfrörer, W., Hund, V., Hallschmid, M., Lipp, H., Häring, H., Preissl, H., Fritsche, A., & Heni, M. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13279 · Cited by 110
Metadata
- Authors
- Shah, R., Shah, V., Patel, M., & Maahs, D.
- Venue
- International Journal of Pharmaceutical Investigation
- Publisher
- Manuscript Technomedia LLP
- Published
- 2016
- Volume
- 6
- Issue
- 1
- Pages
- 1
- ISSN
- 2230-9713 (ISSN-L)
- 2230-973X
- OpenAlex
- W2281837728
- Cited by
- 287
- References
- 76
- FWCI
- 17.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.